Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antitrust
Pharma
FTC to review Novo Holdings' Catalent buyout for 30 more days
After Novo Holdings pitched a $16.5 billion buyout of Catalent in February, the companies have given the FTC extra time to review the deal.
Fraiser Kansteiner
Apr 8, 2024 11:58am
Teva, like Hikma, accuses Amarin of hoarding Vascepa ingredient
Mar 29, 2024 1:10pm
Appeals court backs Regeneron's antitrust suit against Novartis
Mar 19, 2024 10:40am
Sandoz ponies up $265M to settle lingering price-fixing case
Feb 29, 2024 10:49am
Pfizer quells 12 years of Lipitor antitrust litigation with $93M
Feb 15, 2024 11:11am
FTC takes patent scrutiny to Sanofi, Mylan's insulin case
Nov 21, 2023 11:34am